The largest database of trusted experimental protocols

2 protocols using phospho pi3k p85 p55

1

Rg3-Enriched Red Ginseng Extract Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rg3-RGE was obtained from Korea Ginseng Corporation (Daejeon, Korea). In brief, red ginseng (stem/root = 75:25) was extracted with water followed by extraction with 55% ethanol. A concentrated extract was prepared by multiple extractions. Consequently, the extract was subjected to GC-MS and the resulting extract constituent profile is shown in Table 1, which confirms that the extract is Rg3-enriched red ginseng extract. Collagen was obtained from Chrono-Log Co. (Havertown, PA, USA). Fura-2/AM and dimethyl sulfoxide were purchased from Sigma Chemical Co. (St. Louis, MO, USA). ATP (adenosine triphosphate) assay kits were obtained from Biomedical Research Service Center (Buffalo, NY, USA). Fibrinogen Alexa Fluor 488 conjugate was purchased from Molecular Probes (Eugene, OR, USA). Antibodies directed against total-ERK1/2 (p44/42), phospho-ERK1/2 (p44/42), total-JNK, phospho-JNK, total-p38, phosphor-p38, total-PI3K (phosphatidylinositol 3 kinase) p85/p55, phospho-PI3K p85/p55, total-Akt (Ser473), phospho-Akt (Ser473), total-MKK4 (mitogen-activated protein kinase kinase 4), and phospho-MKK4 were purchased from Cell Signaling (Beverly, MA, USA). All chemicals used were of reagent grade.

Rg3-enriched red ginseng extract constituent profile

Table 1
GinsenosidesContents (mg/g)
Rb13.86
20(S)-Rg344.91
Rc1.20
Rb21.53
Rd1.60
Rf1.28
Rh13.71
20(S)-Rg23.55
20(R)-Rg36.78
Total67.41
+ Open protocol
+ Expand
2

Western Blot Analysis of Cell Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rat tumor tissues, cultured cells and acetone-precipitated supernatants were lysed in a modified radioimmunoprecipitation assay protein extraction buffer as described previously [4 (link)]. Each sample was applied equally to 8–15% polyacrylamide gels and transblotted to polyvinylidene difluoride membranes (GE healthcare, Uppsala, Sweden). After blocking, primary-antibodies to AKT1 (1:2000, 2938), phospho-AKT1 (1:1000, 9271), Caspase-3 (1:1000, 9665), ERK1/2 (1:1000, 4695), phospho-ERK1/2 (1:1000, 4370), LC3B (1:1000, 3868), mTOR (1:1000, 2972), phospho-mTOR (1:1000, 2971), PI3K p110α (1:1000, 249), phospho-PI3K p85/p55 (1:500, 4228) (Cell Signaling Technology, Inc., Danvers, MA, USA), β-actin (1:1000, sc-47778), EGFR (1:250, sc-03), ErbB2 (1:1000, sc-284), ErbB3 (1:1000, sc-285), phospho-ErbB2 (1:500, sc-81508), phospho-ErbB3 (1:250, sc-135654), HIF-1α (1:1000, sc-53546), GAPDH (1:2000, sc-20357) (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), phospho-EGFR (1:1000, 44-790G; Thermo Fisher Scientific), αSMA (1:2000, ab32575; abcam), E-cadherin (1:2000, 610181; BD Biosciences) and HCaRG (1:2000) were incubated overnight, followed by incubation with secondary horseradish-peroxidase conjugated-antibodies (Santa Cruz Biotechnology, Inc.) for 60 minutes. Immunocomplexes were detected by enhanced chemiluminescence (PerkinElmer Life Sciences).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!